Posts by Motaz Qadan, MD, PhD
-
Neoadjuvant Therapy Safe, Effective for Elderly Patients With Pancreatic Ductal Adenocarcinoma
Guoliang Qiao, MD, PhD, Motaz Qadan, MD, PhD, and colleagues demonstrated patients ≥75 years old with pancreatic ductal adenocarcinoma were associated with longer overall and recurrence-free survival if they underwent neoadjuvant chemotherapy instead of upfront surgical resection; postoperative complication rates were similar.
-
Treating Liver Cancer Using Hepatic Arterial Infusion Pumps
Physicians at Massachusetts General Hospital are refining the use of hepatic arterial infusion pumps for targeted delivery of chemotherapy to treat liver metastases.
-
Advances in Prehabilitation
Motaz Qadan, MD, PhD, is a hepatobiliary and pancreatic surgical oncologist in the Mass General Cancer Center and a surgeon in the Division of Gastrointestinal and Oncologic Surgery. In this video, he discusses his research on prehabilitation and its promising potential for patients with pancreatic cancer.
-
Size of Largest Colorectal Liver Metastasis is an Independent Prognostic Factor After Neoadjuvant Therapy
In patients with colorectal cancer metastasis confined to the liver, Motaz Qadan, MD, PhD, of the Department of Surgery, found that larger metastases predict poorer disease-free and disease-specific survival after neoadjuvant chemotherapy and liver resection.
-
Five Sessions to See at Digestive Disease Week 2021
At Digestive Disease Week 2021, clinicians and researchers from the Massachusetts General Hospital Divisions of Gastroenterology and Gastrointestinal & Oncologic Surgery present their world-leading research and innovative treatment approaches.
-
Editorial: Document Patients' Wishes About Surgery at the End of Life
Adding a do-not-operate section to advanced planning forms would improve documentation of patients' wishes about invasive interventions at the end of life.
Biography
Motaz Qadan, MD, PhD, is a surgical oncologist at the Massachusetts General Hospital. His practice includes pancreatic and liver surgery operations. Patient information videos about his most commonly performed operations are included below:
Dr. Qadan's leadership positions include:
- Complex General Surgical Oncology Fellowship Program Director at the Mass General
- Harvard Medical Student Advanced Surgical Clerkship Director
- Pancreas Cyst Multidisciplinary Clinic Director
- Partners Network Resident and Fellow Wellbeing Council Faculty Advisor
Dr. Qadan received his undergraduate and medical degrees from the University of Edinburgh Medical School, which is among the top medical schools in Western Europe. He completed surgical residency at Stanford University, where he served as administrative chief resident. Following this, he completed a fellowship in complex general surgical oncology at the Memorial Sloan Kettering Cancer Center in New York and served as the educational coordinator during his fellowship.
Dr. Qadan is also a Fellow of the American College of Surgeons (FACS) and a Member of the Royal College of Surgeons of Edinburgh (MRCSEd). He is a surgical member of the multidisciplinary cancer team at the Mass General in Boston.